Cytek Biosciences (CTKB) Raw Materials (2020 - 2026)

Cytek Biosciences (CTKB) has 7 years of Raw Materials data on file, last reported at $23.6 million in Q1 2026.

• For the quarter ending Q1 2026, Raw Materials changed 0.4% year-over-year to $23.6 million; the trailing twelve-month figure through Mar 2026 stood at $23.6 million (changed 0.4% YoY), and the FY2025 full-year result was $20.4 million, down 9.43% from the prior year.
• Raw Materials for Q1 2026 stood at $23.6 million, up from $20.4 million in the prior quarter.
• Across five years, Raw Materials topped out at $42.2 million in Q1 2023 and bottomed at $20.4 million in Q4 2025.
• The 5-year median for Raw Materials is $26.8 million (2024), against an average of $28.7 million.
• The widest annual swing landed in 2023, when Raw Materials soared 99.18%; it then sank 36.81% in 2024.
• A 5-year view of Raw Materials shows it stood at $26.9 million in 2022, then surged by 32.66% to $35.7 million in 2023, then tumbled by 36.81% to $22.6 million in 2024, then declined by 9.43% to $20.4 million in 2025, then increased by 15.65% to $23.6 million in 2026.
• The last three Raw Materials figures came in at $23.6 million (Q1 2026), $20.4 million (Q4 2025), and $24.7 million (Q3 2025), per Business Quant data.

Peer Comparison